COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation
The year 2020 will be carved in the history books—with the proliferation of COVID-19 over the globe and with frontline health workers and basic scientists worldwide diligently fighting to alleviate life-threatening symptoms and curb the spread of the disease. Behind the shocking prevalence of death...
Main Authors: | Jihang Yu, Edouard I. Azzam, Ashok B. Jadhav, Yi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2212 |
Similar Items
-
Low-Dose Radiation Therapy for COVID-19: A Systematic Review
by: Seyed Mohammad Javad Mortazavi, et al.
Published: (2021-09-01) -
METHOD OF ASSESSMENT OF RADIOTHERAPEUTIC INTERVAL IN RADIATION THERAPY FOR CANCER CONSIDERING DOSE FRACTIONATION REGIMEN
by: V. A. Lisin
Published: (2016-07-01) -
Radiation Dose Reduction in Thorax CT
by: Gizem Gul Koc, et al.
Published: (2014-06-01) -
Treating infections with ionizing radiation: a historical perspective and emerging techniques
by: B. van Dijk, et al.
Published: (2020-07-01) -
Modern principles of the radiation protection from sources of ionizing radiation in medicine. Part 1: Trends, structure of x-ray diagnostics and doses from medical exposure
by: G. G. Onischenko, et al.
Published: (2019-03-01)